Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Interaction Study of Rifampicin, Isoniazid and Moxifloxacin in Tuberculosis Patients in Bandung, Indonesia

NCT00306319 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00306319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00306319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Interaction Study of Rifampicin, Isoniazid and Moxifloxacin in Tuberculosis Patients in Bandung, Indonesia
Lead sponsor
Radboud University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
May 31, 2006
Enrollment
23
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis